PL2475361T3 - N-podstawione benzenopropanoamidy do stosowania w leczeniu bólu i stanu zapalnego - Google Patents

N-podstawione benzenopropanoamidy do stosowania w leczeniu bólu i stanu zapalnego

Info

Publication number
PL2475361T3
PL2475361T3 PL10759717T PL10759717T PL2475361T3 PL 2475361 T3 PL2475361 T3 PL 2475361T3 PL 10759717 T PL10759717 T PL 10759717T PL 10759717 T PL10759717 T PL 10759717T PL 2475361 T3 PL2475361 T3 PL 2475361T3
Authority
PL
Poland
Prior art keywords
benzenepropanamides
inflammation
pain
substituted
treatment
Prior art date
Application number
PL10759717T
Other languages
English (en)
Inventor
Eliahu Kaplan
Original Assignee
Novaremed Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novaremed Ltd. filed Critical Novaremed Ltd.
Publication of PL2475361T3 publication Critical patent/PL2475361T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL10759717T 2009-09-09 2010-09-09 N-podstawione benzenopropanoamidy do stosowania w leczeniu bólu i stanu zapalnego PL2475361T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24083909P 2009-09-09 2009-09-09
EP10759717.1A EP2475361B1 (en) 2009-09-09 2010-09-09 N-substituted benzenepropanamides for use in the treatment of pain and inflammation
PCT/IB2010/002247 WO2011030205A1 (en) 2009-09-09 2010-09-09 N-substituted benzenepropanamide or benzenepropenamide for use in the treatment of pain and inflammation

Publications (1)

Publication Number Publication Date
PL2475361T3 true PL2475361T3 (pl) 2020-07-13

Family

ID=43217260

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10759717T PL2475361T3 (pl) 2009-09-09 2010-09-09 N-podstawione benzenopropanoamidy do stosowania w leczeniu bólu i stanu zapalnego

Country Status (10)

Country Link
EP (1) EP2475361B1 (pl)
JP (2) JP2013504555A (pl)
CN (1) CN102821761B (pl)
DK (1) DK2475361T3 (pl)
ES (1) ES2770362T3 (pl)
HK (1) HK1179523A1 (pl)
HU (1) HUE047515T2 (pl)
PL (1) PL2475361T3 (pl)
PT (1) PT2475361T (pl)
WO (1) WO2011030205A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201116335D0 (en) * 2011-09-21 2011-11-02 Novaremed Ltd A method of treating or preventing affective disorders
AU2012348529B2 (en) 2011-12-08 2017-03-30 Novaremed Ltd. Isolated stereoisomeric forms of (S) 2-N (3-O-(propan 2-ol) -1-propyl-4-hydroxybenzene) -3-phenylpropylamide
KR20150100923A (ko) * 2012-12-28 2015-09-02 니폰 조키 세야쿠 가부시키가이샤 신남산 아미드 유도체
CN113329746A (zh) * 2019-01-23 2021-08-31 诺瓦麦有限公司 用于治疗或预防疼痛、炎症和/或自身免疫的化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6423689B1 (en) * 1997-12-22 2002-07-23 Warner-Lambert Company Peptidyl calcium channel blockers
PT1546088E (pt) * 2002-10-03 2015-03-16 Novaremed Ltd Compostos para utilização no tratamento de doenças auto-imunes, de doenças imuno-alérgicas e de rejeição de órgãos ou tecidos transplantados
US7674829B2 (en) * 2004-03-26 2010-03-09 Novaremed Limited Compounds for the treatment of AIDS and other viral diseases
RU2309144C2 (ru) * 2005-03-25 2007-10-27 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Фенилсодержащие n-ацильные производные аминов, способ их получения, фармацевтическая композиция и их применение в качестве противовоспалительных и анальгетических средств
US20090306214A1 (en) * 2006-05-09 2009-12-10 Eliahu Kaplan Use of Syk Tyrosine Kinase Inhibitors for the Treatment of Cell Proliferative Disorders
EA200901077A1 (ru) * 2007-02-09 2010-04-30 Транзим Фарма, Инк. Макроциклические модуляторы грелинового рецептора и их применение
GB0804213D0 (en) * 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain

Also Published As

Publication number Publication date
JP2016053058A (ja) 2016-04-14
CN102821761A (zh) 2012-12-12
WO2011030205A1 (en) 2011-03-17
HUE047515T2 (hu) 2020-04-28
DK2475361T3 (da) 2020-02-17
JP6016179B2 (ja) 2016-10-26
PT2475361T (pt) 2020-02-10
EP2475361B1 (en) 2019-11-06
EP2475361A1 (en) 2012-07-18
JP2013504555A (ja) 2013-02-07
HK1179523A1 (en) 2013-10-04
CN102821761B (zh) 2015-06-10
ES2770362T3 (es) 2020-07-01

Similar Documents

Publication Publication Date Title
HRP20190059T1 (hr) Pripravci za liječenje boli i/ili upale
HK1209100A1 (en) N-substituted benzamides and their use in the treatment of pain n-
EP2651407A4 (en) 3-METHANESULFONYLPROPIONITRILE FOR THE TREATMENT OF INFLAMMATION AND PAIN
EP2334315A4 (en) MEANS AND METHOD OF TREATMENT TREATMENT
IL226049A0 (en) A compound for use in the prevention and/or treatment of skin conditions and skin diseases
HK1173379A1 (en) Compositions comprising tramadol and celecoxib in the treatment of pain
EP2408740A4 (en) COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND PAIN
GB0904044D0 (en) The treatment of inflammatory disorders and pain
EP2387407A4 (en) MEDICAMENT FOR THE TREATMENT OF PAIN AND INFLAMMATION
HK1160471A1 (en) Aminophosphinic derivatives that can be used in the treatment of pain
IL207965A0 (en) N-substitutedbenzenepropanamide ofr denzenepropenamide derivatives for use in the treatment of pain and inflammation
GB0921803D0 (en) Drug composition and its use in therapy
GB0822486D0 (en) Compounds for use in the treatment of pain
GB0919889D0 (en) Drug composition and its use in therapy
HK1179523A1 (en) N-substituted benzenepropanamide or benzenepropenamide for use in the treatment of pain and inflammation n-
GB0921805D0 (en) Drug composition and its use in therapy
GB0919893D0 (en) Drug composition and its use in therapy
GB0910375D0 (en) Drug composition and its use in therapy
GB0817330D0 (en) The treatment of inflammatory disorders and pain
GB0803397D0 (en) The treatment of inflammatory disorders and pain
AU2009902049A0 (en) Treatment of pain and/or inflammation
GB0820986D0 (en) The treatment of inflammatory disorder and pain
GB0920267D0 (en) Drug combination and its use in therapy
GB0921804D0 (en) Drug composition and its use in therapy
GB0919890D0 (en) Drug composition and its use in therapy